Experts Discuss Advances in the Use of BTK Inhibitors for the Treatment of Relapsed/Refractory MCL

Activity

Progress
1
Course Completed
Activity Information

Physicians: Maximum of 2.00 AMA PRA Category 1 Credits

Released: March 20, 2023

Expiration: March 19, 2024

Marco Ladetto
Marco Ladetto, MD
Max Topp
Max Topp, MD
Julie M. Vose
Julie M. Vose, MD, MBA